Safety and Efficacy of ALXN1720 in Adults With Generalized Myasthenia Gravis

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

260

Participants

Timeline

Start Date

November 21, 2022

Primary Completion Date

May 27, 2025

Study Completion Date

August 31, 2027

Conditions
Generalized Myasthenia Gravis
Interventions
COMBINATION_PRODUCT

ALXN1720

Combination product consisting of syringe prefilled with ALXN1720.

COMBINATION_PRODUCT

Placebo

Combination product consisting of syringe prefilled with placebo.

Trial Locations (132)

1015

Research Site, Buenos Aires

1181

Research Site, Ciudad de Buenos Aires

2100

Research Site, Copenhagen

4600

Research Site, Wels

5030

Research Site, Seoul

6020

Research Site, Innsbruck

9000

Research Site, Aalborg

10117

Research Site, Berlin

11000

Research Site, Belgrade

11101

Research Site, Taipei

11772

Research Site, Patchogue

13202

Research Site, Syracuse

13385

Research Site, Marseille

14004

Research Site, Córdoba

14620

Research Site, Rochester

16059

Research Site, Bursa

18000

Research Site, Niš

20007

Research Site, Washington D.C.

20064

Research Site, Lublin

20133

Research Site, Milan

23298

Research Site, Richmond

23561

Research Site, New Taipei City

24127

Research Site, Bergamo

25123

Research Site, Brescia

26506

Research Site, Morgantown

27599

Research Site, Chapel Hill

28034

Research Site, Madrid

28040

Research Site, Madrid

28046

Research Site, Madrid

28702

Research Site, Madrid

29010

Research Site, Málaga

29406

Research Site, North Charleston

30501

Research Site, Gainesville

30912

Research Site, Augusta

31406

Research Site, Savannah

32751

Research Site, Maitland

33612

Research Site, Tampa

34209

Research Site, Bradenton

34452

Research Site, Istanbul

38100

Research Site, Hadera

40225

Research Site, Düsseldorf

40503

Research Site, Lexington

41009

Research Site, Seville

41380

Research Site, Kocaeli

41404

Research Site, Daegu

48202

Research Site, Detroit

48824

Research Site, East Lansing

49241

Research Site, Busan

50139

Research Site, Florence

55139

Research Site, Samsun

56126

Research Site, Pisa

59037

Research Site, Lille

61469

Research Site, Gwangju

62769

Research Site, Springfield

66160

Research Site, Kansas City

67098

Research Site, Strasbourg

70403

Research Site, Tainan City

75651

Research Site, Paris

77030

Research Site, Houston

80131

Research Site, Napoli

80528

Research Site, Fort Collins

81675

Research Site, München

89117

Research Site, Las Vegas

90127

Research Site, Palermo

92380

Research Site, Garches

92868

Research Site, Orange

97074

Research Site, Würzburg

100034

Research Site, Beijing

100730

Research Site, Beijing

130021

Research Site, Changchun

200040

Research Site, Shanghai

215006

Research Site, Suzhou

250014

Research Site, Jinan

266035

Research Site, Qingdao

310003

Research Site, Hangzhou

310016

Research Site, Hangzhou

350001

Research Site, Fuzhou

410008

Research Site, Changsha

430030

Research Site, Wuhan

610041

Research Site, Chengdu

710000

Research Site, Xi'an

833401

Research Site, Kaohsiung City

3109601

Research Site, Haifa

4910000

Research Site, Petah Tikva

AR-CP 1221

Research Site, Buenos Aires

C1192AAW

Research Site, CABA

S2000BZL

Research Site, Rosario

14784-400

Research Site, Barretos

89202-190

Research Site, Joinville

90620-130

Research Site, Porto Alegre

14051-140

Research Site, Ribeirão Preto

41253-190

Research Site, Salvador

15090-000

Research Site, São José do Rio Preto

05403-010

Research Site, São Paulo

T6G 2G3

Research Site, Edmonton

M5G 2C4

Research Site, Toronto

G1J 1Z4

Research Site, Québec

06000

Research Site, Nice

00168

Research Site, Roma

00189

Research Site, Rome

260-8677

Research Site, Chiba

960-1295

Research Site, Fukushima

355-0005

Research Site, Higashimatsuyama-shi

259-1193

Research Site, Isehara-shi

173-8610

Research Site, Itabashi-ku

216-8511

Research Site, Kawasaki-shi

020-8505

Research Site, Morioka

852-8501

Research Site, Nagasaki

466-0065

Research Site, Nagoya

467-0001

Research Site, Nagoya

160-0023

Research Site, Shinjuku-ku

160-8582

Research Site, Shinjuku-ku

565-0871

Research Site, Suita-shi

1105 AZ

Research Site, Amsterdam

85-086

Research Site, Bydgoszcz

40-689

Research Site, Katowice

31-202

Research Site, Krakow

31-505

Research Site, Krakow

61-731

Research Site, Poznan

2805-267

Research Site, Almada

4099-001

Research Site, Porto

02841

Research Site, Seoul

03722

Research Site, Seoul

05505

Research Site, Seoul

06351

Research Site, Seoul

08916

Research Site, Badalona (Barcelona)

08907

Research Site, L'Hospitalet de Llobregat

CH-9007

Research Site, Sankt Gallen

L9 7AL

Research Site, Liverpool

EC1A 7BE

Research Site, London

0X3 7LE

Research Site, Oxford

S10 2JF

Research Site, Sheffield

Sponsors
All Listed Sponsors
lead

Alexion Pharmaceuticals, Inc.

INDUSTRY